Navigation Links
Edison Nation Medical Seeks Product Innovations to Reduce the Incidence of Catheter-Associated Urinary Tract Infections (UTIs)
Date:7/15/2014

CHARLOTTE, N.C., July 15, 2014 /PRNewswire/ -- Edison Nation Medical, a healthcare innovation portal, today announced a worldwide search for medical device, app, and technology solutions aimed at reducing the incidence of Catheter-Associated Urinary Tract Infections (CA-UTIs). Innovation ideas can include, but are not limited to prevention, alternatives to catheterization, early detection, and detecting remotely through monitoring.  Edison Nation Medical will carefully evaluate all ideas submitted and will work to license the most promising innovations, sharing resulting licensing royalties with the inventor(s) involved.

The Edison Nation Medical innovation search is open to the public. Submissions should be made to Edison Nation Medical's confidential and secure online portal at www.EdisonNationMedical.com/UTI now through Monday, September 8, 2014. 

Urinary catheters are a commonly used medical device that allows for continuous urine drainage in patients.  Urinary catheters are used in the acute care setting in both men and women.  It is estimated that 15%-25% of patients may have a urinary catheter inserted sometime during their hospital stay, with most used on a short-term basis.  Once a catheter is placed, the percentage of patients developing bacteriuria (bacterial infection) increases from 3-10% for those catheterized less than a day to 90% in long-term catheterization

Urinary tract infections (UTIs) associated with urinary catheters account for approximately 40% of all hospital-acquired infections in the United States.  Infections resulting from catheter-associated UTIs are generally more resistant to common antibiotics and can be harder to treat than other UTIs.  Complications from Catheter-Associated UTIs cause discomfort to the patient, prolonged hospital stay, increased cost and mortality.  More than 13,000 deaths annually are associated with UTIs.  Estimates of the  total cost in the United States ranges from $400-500 million annually.

Robert Grajewski, president of Edison Nation Medical, stated "Catheter-Associated UTIs are one of the biggest preventable acute-care sources of infection.  We believe great solutions are in the minds of people around the world and our goal is find those disruptive healthcare ideas to both improve patient safety and reduce costs." 

Joining Edison Nation Medical is free.  Ideas submitted to the organization's confidential and secure online portal cost only $25 to submit and are vetted through an in-depth review process led by a team of medical, product development and legal experts. The end goal is to commercialize each qualified product idea and, when Edison Nation Medical is successful, licensing royalties are shared with the submitting inventor(s).

Inventors are encouraged to submit everything from a back-of-the-envelope sketch to patented and prototype ideas to currently commercialized products looking to scale.

For more information and to submit an idea, go to www.EdisonNationMedical.com/UTI

About Edison Nation Medical:

Edison Nation Medical is a healthcare innovation portal with deep expertise in open innovation, product development, and healthcare. Born out of collaboration with Carolinas HealthCare System (the second largest public health system in the United States), Edison Nation Medical's mission is to break down the barriers to healthcare innovation. We make this a reality by providing a clear and easy pathway through our open innovation platform for anyone — physicians, nurses, entrepreneurs, even patients and caregivers — to submit a medical invention idea for full evaluation and potential commercialization.

Edison Nation Medical innovation headquarters is in Charlotte, NC with satellite offices in San Francisco and New York City. For more information, please visit www.EdisonNationMedical.com.


'/>"/>
SOURCE Edison Nation Medical
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Edison highlights the potential of GW Pharmaceuticals cannabinoid pipeline and furthers its US healthcare presence
2. Bavarian Nordic, the international novel cancer and infectious disease vaccines focused biotech, now covered by Edison.
3. Edison Expands its Asia-Pac Pharmaceutical Presence with Launch of Coverage of Mesoblast
4. Edison expands international bio-pharmaceutical presence with launch of coverage of Onconova Therapeutics
5. Edison Pharmaceuticals Announces Initiation of NIH-Sponsored EPI-743 Clinical Trial with NIH Undiagnosed Diseases Program Patients
6. Edison initiates coverage of Derma Sciences
7. Edison expands North American healthcare sector coverage with initiation of coverage on Alexza Pharmaceuticals
8. Edison Expands North American Healthcare Sector Coverage With Initiation of Coverage on Bellus Health
9. Edison Pharmaceuticals, Inc. signs licensing agreement with Dainippon Sumitomo Pharma Co., Ltd. for development & commercialization of orphan mitochondrial and adult central nervous system disease drugs
10. Edison Pharmaceuticals & Bambino Gesu Childrens Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C Deficiency Syndrome Clinical Trial
11. Samsung Medison Showcases New Medical Equipment and Technology with Samsung Electronics at RSNA 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 2017 Research and Markets has announced ... & Forecast By Type (Insource IONM, Outsource IONM), By Region ... their offering. ... The global Intraoperative Neuromonitoring (IONM) market is expected ... market is anticipated to witness significant growth in the forecast ...
(Date:3/29/2017)... Research and Markets has announced the addition ... their offering. ... The global gas chromatograph market to grow at a CAGR of ... Gas Chromatograph Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:3/29/2017)... HANOVER, N.J. , March 29, 2017 /PRNewswire/ ... Drug Administration (FDA) has accepted the company,s Biologics ... for CTL019 (tisagenlecleucel-T), an investigational chimeric antigen receptor ... (r/r) pediatric and young adult patients with B-cell ... BLA submission by Novartis for a CAR-T. The ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER AS , BALTIMORE WOMEN’S CLASSIC ... as the official title sponsor of the Baltimore Women’s Classic, the largest all women’s ... will walk or run the course around the Baltimore Inner Harbor. Mercy has been ...
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy ... attending prescribers at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. ... recognized as the visionary leader in the training of physicians, scientists, and members ...
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... Library for documenting and diagramming network and data center assets and audio-video devices ... subscribers can request new equipment shapes for free and download shapes and stencils ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... in many scientific laboratories. The assembly protocols involve many repetitive steps and often ... for automation, which enables the high-throughput needed, and results in a lower error ...
Breaking Medicine News(10 mins):